JASVINDER SINGH to Cardiovascular Diseases
This is a "connection" page, showing publications JASVINDER SINGH has written about Cardiovascular Diseases.
Connection Strength
1.566
-
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits. Curr Rheumatol Rep. 2023 12; 25(12):295-306.
Score: 0.358
-
Infection versus cardiovascular disease as leading causes of hospitalisations and associated mortality in vasculitis in the U.S.: a national study. Clin Exp Rheumatol. 2021 Mar-Apr; 39 Suppl 129(2):56-61.
Score: 0.290
-
Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction? Drugs Aging. 2019 06; 36(6):493-510.
Score: 0.261
-
Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data. BMC Neurol. 2019 Jan 05; 19(1):4.
Score: 0.254
-
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes. BMC Cardiovasc Disord. 2017 03 14; 17(1):76.
Score: 0.224
-
Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020 06; 50(3S):S11-S16.
Score: 0.070
-
Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis. Ann Rheum Dis. 2016 Oct; 75(10):1813-8.
Score: 0.052
-
Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am. 2014 May; 40(2):251-78.
Score: 0.045
-
Remembering the forgotten non-communicable diseases. BMC Med. 2014 Oct 22; 12:200.
Score: 0.012